Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents

The myeloid cell leukemia 1 (Mcl-1) protein has emerged as an attractive target for the development of anti-cancer therapy. This review highlights recent advances in the discovery of small-molecule Mcl-1 inhibitors from 2012 to 2017.241